Sharon Shechter

Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia

Rosa Lapalombella, Qingxiang Sun, Katie Williams et al. · Blood · 2012 · 297 citations · Full text

Medicine, Cell Biology, Oncology +9

Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry

Tom Dixon, Derek MacPherson, Barmak Mostofian et al. · Nature Communications · 2022 · 101 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors

Ori Kalid, Dora Toledo Warshaviak, Sharon Shechter et al. · Journal of Computer-Aided Molecular Design · 2012 · 77 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription

Damien Gerald, Irit Adini, Sharon Shechter et al. · Nature Communications · 2013 · 64 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Endothelial Akt Signaling Is Rate-Limiting for Rapamycin Inhibition of Mouse Mammary Tumor Progression

Thuy L. Phung, Godfred Eyiah-Mensah, Rebekah K. O’Donnell et al. · Cancer Research · 2007 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17